Pharma Research Library | Pharma Info Index Research | Innovation | Opportunities |

Narendra Kumar Reddy Kolli*1, Swetha Polagani1, Bharghava Bhushana Rao Pathange2 1Sri Vani School of Pharmacy, Chevuturu, Vijayawada, AP. India 2VVIPS, Gudlavalleru, Krishna Dt, AP, India A  B S T R A C T Desvenlafaxine (DVS) was a novel serotonin (5-HT) that was currently in clinical development for the treatment of major depressive disorder and vasomotor symptoms associated with menopause. Desvenlafaxine ... Read More »